Latest Breaking News On - India formulations - Page 5 : comparemela.com

Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer HER2-positive, and the company markets its version in India under the brand name Trumab .

Glenmark pharmaAlok malikGlenmark pharmaceuticals ltd onGlenmark pharmaceuticals executive vicePharmaceuticals ltdPharmaceuticals executive vice presidentIndia formulations

Trastuzumab price: Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer HER2-positive, and the company markets its version in India under the brand name Trumab . It is now priced at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier.

Alok malikGlenmark pharmaceuticals ltd onGlenmark pharmaceuticals executive vicePharmaceuticals ltdPharmaceuticals executive vice presidentIndia formulations

Glenmark Pharma slashes breast cancer drug price by 70% - The Hindu BusinessLine

Glenmark Pharma slashes breast cancer drug price by 70% - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Glenmark pharmaAlok malikGlenmark pharmaceuticalsExecutive vice presidentIndia formulations

The Rise of The Suncare

The Indian sunscreen market is among the fastest growing in the skincare market, prompting many brands and startups to make a foray into the category, , Magazine 03 June 2023

India generalShailey mehrotraPriyanka sachdevaAlok malikMohit yadavPrakher mathurEstee lauderGlenmark pharmaceuticalsStatista market insightsHindustan unileverLotus herbalsAroma magicExecutive vice presidentIndia formulationsManaging directorConscious chemist

Lower API costs should start benefiting now, to lend comfort on FY23-25 margin expansion

Analysts at IIFL Securities have analyzed import pricing for 16 key APIs/KSMs imported into India. This study shows that API import costs (weighted average) have declined marginally by 2% QoQ in Q1CY23, after having corrected 8% QoQ and 6% QoQ in Q4CY22 and Q3CY22 respectively from the peaks seen in Q2CY22.

Apis ksmsPricing indexPricing indexWhile pen gIndia formulations